Technology | August 12, 2013

Ambio Remote Health Monitoring System Secures FDA 510(k) Clearance

Wireless remote system optimized for long-term care, affordability and ease of use for patients

August 12, 2013 — Ambio Health, a healthcare technology company specializing in health monitoring systems, announced its Ambio remote health monitoring system, a wireless remote health and activity monitoring tool, received Class II 510(k) clearance from the U.S. Food and Drug Administration (FDA). The system can track health information for patients with high blood pressure, heart disease and diabetes.

“Our goal at Ambio is to enable individuals to take health readings at home and get connected to health care providers, loved ones and caregivers who may not be able to visit every day,” said Kevin Jones, CEO at Ambio Health. “We are very pleased to have realized the important milestone of FDA 510(k) clearance so quickly, as it means we will be able to make this product readily available to those who need it.”

The Ambio remote health monitoring system was launched in January 2013 at the Consumer Electronics Show and named as one of eWeek’s “10 Health and Fitness Tools To Track Exercise, Chronic Conditions.” The system offers patients:

  • Home health readings that are automatically logged and can be viewed by family members and caregivers from the secure, Web-based Ambio Care Portal;
  • Accurate and complete readings that are available to healthcare providers for the regular monitoring of patient health;
  • The ability to set individualized alert levels and notifications of exception conditions;
  • Individualized reminders for readings and medications that can be sent to the patient via telephone call, text message or email;
  • An affordable system designed to work with a number of health monitors; and
  • A HIPAA compliant tool that keeps health information private and secure.

The system’s price starts at $49.97 for a single device, which includes a wireless glucose meter, and the user then pays an annual subscription that is the equivalent of $4.99 per month. Additional devices with wireless connectivity include a blood pressure meter and a weight scale and can be added à la carte.

Jason C. Baker, M.D., with Weill Cornell Physicians, noted: “Ambio is uniquely designed to also provide an interface on the critical measures of blood pressure and weight, which are key pieces in controlling the diabetes puzzle. The Ambio dashboard provides a comprehensive, yet straight-forward, overview of glucose control and can be personalized to meet the needs of individual patients and providers.”

For more information:

Related Content

First Canadian Patient Implanted With CardioMEMS Heart Failure Sensor
News | Heart Failure| June 23, 2017
In a Canadian first, a medical team has implanted the wireless CardioMEMS HF device inside a heart failure patient. The...
Northwell Health Partners With Peerbridge Health on Remote Patient Monitoring
News | Wearable Sensors| June 01, 2017
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Biotronik Home Monitoring implanted EP device remote wireless monitoring system
News | May 24, 2017
May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces th
Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Apple Watch used for tracking patient arrhythmias using an artificial intelligence-based algorithm

Researchers are using the Apple Watch heart rate monitor app to track patient arrhythmias using an artificial intelligence-based algorithm. 

Feature | Wearable Sensors| May 11, 2017
May 11, 2017 — A new study shows that the Apple Watch's heart rate sensor, when paired with an artificial intelligenc
Acarix, CADScor System, coronary artery disease detection, clinical study, ACC.17
News | Patient Monitors| March 30, 2017
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive...
heart monitoring technology, climbers, high altitudes, Circulation study, cardiac diagnostics, Medtronic, Reveal LINQ
News | Implantable Cardiac Monitor (ICM)| March 14, 2017
Climbing above 4,000 meters can provoke abnormal heart rhythms in otherwise healthy mountaineers, with the...
wearable biosensors, anticipate illness, track health changes, PLOS Biology study

Wearable devices used in this study. The colors for different human figures indicate the specific studies in which each person participated. Red figures represent participation in all five studies; grey figures represent participation in the activity and insulin studies; blue, the activity, insulin sensitivity, and inflammation studies; orange and yellow, activity and air flights; green and pink, inflammation; and purple, air flights. Image courtesy of Li, et al, Stanford University.

News | Wearable Sensors| March 14, 2017
Researchers supported by the National Institutes of Health have revealed the ability of wearable biosensors, similar to...
Frost & Sullivan, Healthcare Industry Outlook 2017 analysis, information technology, healthcare IT
News | Information Technology| March 08, 2017
Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set...
Overlay Init